Enhancing pathways to therapeutic development with clinical biomarkers
Am J Geriatr Psychiatry
.
2002 Nov-Dec;10(6):646-8.
doi: 10.1176/appi.ajgp.10.6.646.
Author
Gregory J Downing
1
Affiliation
1
Office of Science Policy and Planning, Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, MD, USA. gd34f@nih.gov
PMID:
12427572
DOI:
10.1176/appi.ajgp.10.6.646
No abstract available
MeSH terms
Aged
Biomarkers*
Humans
Mental Disorders / drug therapy*
Pharmaceutical Preparations*
Research Design*
Substances
Biomarkers
Pharmaceutical Preparations